June 8, 2020 / 11:52 AM / a month ago

BRIEF-Heat Biologics Announces FDA Clearance Of Investigational New Drug Application For PTX-35

June 8 (Reuters) - Heat Biologics Inc:

* HEAT BIOLOGICS - ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR PTX-35

* HEAT BIOLOGICS - CO'S PELICAN THERAPEUTICS UNIT HAS NEAR-TERM PLANS TO INITIATE ITS PHASE 1 CLINICAL TRIAL IN PATIENTS WITH SOLID TUMORS Source text: (bit.ly/3dKPHue) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below